Critical Contrast: Relmada Therapeutics (NASDAQ:RLMD) and Clearmind Medicine (NASDAQ:CMND) June 6, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by thelincolnianonline. Read more Source: https://www.thelincolnianonline.com/2026/06/05/critical-contrast-relmada-therapeutics-nasdaqrlmd-and-clearmind-medicine-nasdaqcmnd.html